ArcticZymes Technologies — Director's Dealing 2017

May 3, 2017

Biotec Pharmacon - Mandatory notification of trade

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 03. May 2017) Rolf E. Engstad, CSO of Biotec BetaGlucans has today

purchased 30 000 shares in Biotec Pharmacon at NOK 5.78 per share. After this

transaction holds Engstad 350.774 shares and 110.000 options in Biotec

Pharmacon

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187

borge.sorvoll@biotec.no